JnJ 54767414

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
28	全身性アミロイドーシス	11

28. 全身性アミロイドーシス

臨床試験数 : 267 / 薬物数 : 241 - (DrugBank : 77) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 180

trials per page:

Showing 1 to 10 of 11 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2016-001737-27-GB (EUCTR)	08/10/2018	11/01/2018	A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bor ...	A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cy ...	AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis ) MedDRA version: 20.0;Level: PT;Classificat ...	Product Name: Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) Product Code: ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	370	Phase 3	United States;Greece;Spain;Turkey;Israel;Italy;United Kingdom;France;Hungary;Mexico;Canada;Poland;Be ...
2	EUCTR2016-001737-27-PL (EUCTR)	06/09/2018	16/07/2018	A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bor ...	A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cy ...	AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis ) MedDRA version: 20.0;Level: PT;Classificat ...	Product Name: Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) Product Code: ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	370	Phase 3	United States;Greece;Spain;Turkey;Israel;United Kingdom;Italy;France;Hungary;Mexico;Canada;Belgium;P ...
3	EUCTR2016-001737-27-DK (EUCTR)	22/08/2018	04/06/2018	A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bor ...	A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cy ...	AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis ) MedDRA version: 20.0;Level: PT;Classificat ...	Product Name: Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) Product Code: ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	370	Phase 3	United States;Greece;Spain;Turkey;Israel;Italy;United Kingdom;France;Hungary;Mexico;Canada;Poland;Be ...
4	EUCTR2016-001737-27-SE (EUCTR)	07/05/2018	20/11/2017	A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bor ...	A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cy ...	AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis ) MedDRA version: 20.0;Level: PT;Classificat ...	Product Name: Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) Product Code: ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	370	Phase 3	United States;Greece;Spain;Turkey;Israel;Italy;United Kingdom;France;Hungary;Mexico;Canada;Poland;Be ...
5	EUCTR2016-001737-27-DE (EUCTR)	16/04/2018	16/11/2017	A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bor ...	A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cy ...	AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis ) MedDRA version: 20.0;Level: PT;Classificat ...	Product Name: Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) Product Code: ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	370	Phase 3	United States;Greece;Spain;Turkey;Israel;Italy;United Kingdom;France;Hungary;Mexico;Canada;Poland;Be ...
6	EUCTR2016-001737-27-GR (EUCTR)	16/04/2018	22/03/2018	A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bor ...	A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cy ...	AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis ) MedDRA version: 20.0;Level: PT;Classificat ...	Product Name: Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) Product Code: ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	370	Phase 3	United States;Greece;Spain;Turkey;Israel;Italy;United Kingdom;France;Hungary;Mexico;Canada;Poland;Be ...
7	EUCTR2016-001737-27-NL (EUCTR)	15/03/2018	29/11/2017	A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bor ...	A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cy ...	AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis ) MedDRA version: 20.0;Level: PT;Classificat ...	Product Name: Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) Product Code: ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	370	Phase 3	United States;Greece;Spain;Turkey;Israel;Italy;United Kingdom;France;Hungary;Mexico;Canada;Poland;Be ...
8	EUCTR2016-001737-27-IT (EUCTR)	01/03/2018	17/06/2021	A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bor ...	A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cy ...	AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis) MedDRA version: 20.0;Level: PT;Classificati ...	Product Name: daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20) Product Code: [Jn ...	JANSSEN CILAG INTERNATIONAL NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	370	Phase 3	United States;Greece;Spain;Turkey;Israel;United Kingdom;Italy;France;Hungary;Mexico;Canada;Poland;Br ...
9	EUCTR2016-001737-27-ES (EUCTR)	06/02/2018	23/11/2017	A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bor ...	A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cy ...	AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis ) MedDRA version: 20.0;Level: PT;Classificat ...	Product Name: Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) Product Code: ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	370	Phase 3	United States;Greece;Spain;Turkey;Israel;Italy;United Kingdom;France;Hungary;Mexico;Canada;Poland;Be ...
10	EUCTR2016-001737-27-HU (EUCTR)	25/01/2018	28/11/2017	A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bor ...	A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cy ...	AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis ) MedDRA version: 20.0;Level: PT;Classificat ...	Product Name: Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) Product Code: ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	370	Phase 3	United States;Greece;Spain;Turkey;Israel;Italy;United Kingdom;France;Hungary;Mexico;Canada;Poland;Be ...

First Previous1 2Next Last